Finland - Medical devices, pharmaceutical products and personal hygiene products - Participation notice: Haartmaninkatu 3 Pathology and Genetics alterations, procurement section KSL 1

different companies won its awards

28

of the awards went to the three most frequent winners

11%

of its calls state an estimated value

29%

Based on 28 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.

Competition

tenders per lot on average (open and restricted procedures)

4.9

of those lots received a single tender

3%

of the awards went to companies based in another country

0%

As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.

Finland · Medical equipment & pharmaceuticals

different companies won awards here

414

of the awards went to the three most frequent winners

8%

buyers awarded contracts here

164

Based on 616 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.

Competition

tenders per lot on average (open and restricted procedures)

3.0

of those lots received a single tender

17%

of the awards went to companies based in another country

9%

of the tenders came from another country

2%

As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.